Prostperia
Personalized prostate cancer screening test combining PSA results and patient data, for patients and urologists
Highlights
- New on EvolcAdded 2026-11-02
About Prostperia
Prostperia develops PROSTia, a personalized in-silico screening test for the early detection of prostate cancer. The test combines a standard PSA test result with over 60 patient features, a short patient questionnaire and an AI analysis, and shows the likelihood of prostate cancer within 12 years. PROSTia holds CE marking as an in-vitro medical diagnostic device.
The customers are patients and medical professionals; the test is used by urologists.
The company was founded in 2021 in Nancy, France, and its research began in 2013. It developed PROSTia with CHRU Nancy, and the test was validated on a retrospective cohort of 34,000 patients. Prostperia received the Start-up of the Year 2024 award at Healthcare Week Luxembourg, among other awards. Its team includes a CEO with R&D responsibilities, a CTO and a product and UX lead.
Product: PROSTia, a personalized in-silico prostate cancer screening test based on PSA results, patient features and a questionnaire.
Jobs at Prostperia
More health & medtech companies
Psy N You
Online psychological consultations connecting patients in France with psychologists by video, phone or chatNew on EvolcPulse Sante
Healthcare management software for French home-care medical service providers and medical equipment suppliersNew on EvolcPyxyo
Develops patented digital health, connected-device and cognitive-modulation technologies for healthcare and other specialized marketsNew on Evolcqare.fr
Online medical teleconsultations with registered French doctors for patients in France, available 7 days a weekNew on EvolcRemote-friendlyQuantificare
2D and 3D imaging systems and clinical imaging services for clinical-trial sponsors and aesthetics practitionersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- SquarespaceHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.